HCP, Inc.s in-depth stock price analysis indicates that the stock price has rallied 7.04% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -20.75% . Looking at the past 52 week period, the stock price is up at 16.91% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of HCP, Inc. has a negative value of -8.78 compared to overall market performance. HCP, Inc. (NYSE:HCP) has tumbled 0.16% during the past week, however, the bigger picture is still very bullish; the stocks have advanced and posted positive gains of 1.59% in the last four weeks. The stocks are negative as compared to the S&P 500 for the past week with a loss of 0.97%. HCP, Inc. (NYSE:HCP) has underperformed the index by 0.23% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
HCP, Inc. (NYSE:HCP) : On Friday heightened volatility was witnessed in HCP, Inc. (NYSE:HCP) which led to swings in the share price. The stock opened for trading at $30.61 and hit $30.805 on the upside , eventually ending the session at $30.7, with a gain of 0.07% or 0.02 points. The heightened volatility saw the trading volume jump to 3,180,285 shares. The 52-week high of the share price is $36.50149 and the company has a market cap of $14,367 million. The 52-week low of the share price is at $22.670468 .
HCP Last issued its quarterly earnings results on Nov 1, 2016. The company reported $0.72 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $0.71.Analysts expectations of $ 626.34.During the same quarter in the previous year, the company posted $0.79 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.HCP was Upgraded by Goldman to Buy on Jan 25, 2017. HCP was Resumed by Barclays on Jan 5, 2017 to Equal Weight, Price Target of the shares are set at $32.HCP was Upgraded by Mizuho on Nov 21, 2016 to Buy, Price Target of the shares are set at $32.
Company has reported several Insider transactions to the SEC, on Jan 31, 2017, Thomas Klaritch (Senior Managing Director) sold 16,519 shares at 40.15 per share price.On Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at 40.24 per share price.On Sep 1, 2016, Darren A Kowalske (Executive Vice President) sold 2,250 shares at 39.20 per share price.
Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.